Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
1.000 | 0.080 | 14 | 68221985 | intron variant | C/T | snv |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.700 | 1.000 | 1 | 2012 | 2012 | ||||||||
|
14 | 68664876 | intron variant | G/A;T | snv |
|
0.700 | 1.000 | 1 | 2019 | 2019 | |||||||||||
|
1.000 | 0.080 | 14 | 68221922 | intron variant | T/C | snv | 0.18 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.700 | 1.000 | 1 | 2012 | 2012 | |||||||
|
0.708 | 0.280 | 14 | 68559662 | intron variant | G/A | snv | 0.23 |
|
Digestive System Diseases; Neoplasms | 0.700 | 1.000 | 1 | 2016 | 2016 | |||||||
|
0.708 | 0.280 | 14 | 68559662 | intron variant | G/A | snv | 0.23 |
|
Digestive System Diseases; Neoplasms | 0.700 | 1.000 | 1 | 2016 | 2016 | |||||||
|
0.708 | 0.280 | 14 | 68559662 | intron variant | G/A | snv | 0.23 |
|
Neoplasms | 0.700 | 1.000 | 1 | 2016 | 2016 | |||||||
|
0.708 | 0.280 | 14 | 68559662 | intron variant | G/A | snv | 0.23 |
|
Neoplasms; Male Urogenital Diseases | 0.700 | 1.000 | 1 | 2016 | 2016 | |||||||
|
0.708 | 0.280 | 14 | 68559662 | intron variant | G/A | snv | 0.23 |
|
Digestive System Diseases; Neoplasms | 0.700 | 1.000 | 1 | 2016 | 2016 | |||||||
|
0.708 | 0.280 | 14 | 68559662 | intron variant | G/A | snv | 0.23 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases | 0.700 | 1.000 | 1 | 2016 | 2016 | |||||||
|
0.708 | 0.280 | 14 | 68559662 | intron variant | G/A | snv | 0.23 |
|
0.700 | 1.000 | 1 | 2016 | 2016 | ||||||||
|
0.708 | 0.280 | 14 | 68559662 | intron variant | G/A | snv | 0.23 |
|
0.700 | 1.000 | 1 | 2016 | 2016 | ||||||||
|
0.708 | 0.280 | 14 | 68559662 | intron variant | G/A | snv | 0.23 |
|
Neoplasms | 0.700 | 1.000 | 1 | 2016 | 2016 | |||||||
|
0.708 | 0.280 | 14 | 68559662 | intron variant | G/A | snv | 0.23 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.700 | 1.000 | 1 | 2016 | 2016 | |||||||
|
0.708 | 0.280 | 14 | 68559662 | intron variant | G/A | snv | 0.23 |
|
Digestive System Diseases; Neoplasms | 0.700 | 1.000 | 1 | 2016 | 2016 | |||||||
|
0.708 | 0.280 | 14 | 68559662 | intron variant | G/A | snv | 0.23 |
|
Neoplasms; Respiratory Tract Diseases | 0.700 | 1.000 | 1 | 2016 | 2016 | |||||||
|
0.708 | 0.280 | 14 | 68559662 | intron variant | G/A | snv | 0.23 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases | 0.700 | 1.000 | 1 | 2016 | 2016 | |||||||
|
0.708 | 0.280 | 14 | 68559662 | intron variant | G/A | snv | 0.23 |
|
0.700 | 1.000 | 1 | 2016 | 2016 | ||||||||
|
0.708 | 0.280 | 14 | 68559662 | intron variant | G/A | snv | 0.23 |
|
Digestive System Diseases; Neoplasms | 0.700 | 1.000 | 1 | 2016 | 2016 | |||||||
|
0.708 | 0.280 | 14 | 68559662 | intron variant | G/A | snv | 0.23 |
|
Neoplasms; Respiratory Tract Diseases | 0.700 | 1.000 | 1 | 2016 | 2016 | |||||||
|
0.708 | 0.280 | 14 | 68559662 | intron variant | G/A | snv | 0.23 |
|
0.700 | 1.000 | 1 | 2016 | 2016 | ||||||||
|
14 | 68406810 | intron variant | T/G | snv | 0.44 |
|
0.700 | 1.000 | 1 | 2019 | 2019 | ||||||||||
|
1.000 | 0.080 | 14 | 68200005 | intron variant | T/C | snv | 0.15 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.700 | 1.000 | 1 | 2012 | 2012 | |||||||
|
1.000 | 0.080 | 14 | 68201782 | intron variant | C/A | snv | 0.17 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.700 | 1.000 | 1 | 2012 | 2012 | |||||||
|
1.000 | 0.080 | 14 | 68201811 | intron variant | C/T | snv | 0.15 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.700 | 1.000 | 1 | 2012 | 2012 | |||||||
|
1.000 | 0.080 | 14 | 68205986 | intron variant | G/A | snv | 0.17 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.700 | 1.000 | 1 | 2012 | 2012 |